and -49(G > T) from the transcription start site. We could demonstrate that the variants -186(GGGC)5 (p < 0.05), and -49T (p = 0.05) were significantly or strongly associated with colorectal cancer as compared to the healthy controls. We found the highest promoter activity to be associated with -186(GGGC)3 and -49T. Conclusion: Our data demonstrate that MMP-9 (-1562 C/T) polymorphism may modify susceptibility to prostate cancer. We hypothesized that this polymorphism might act as a genetic modifier in the development and progression of prostate cancer.
Methods and Materials: DNA from the cancer patients' blood was extracted and amplified with PCR. PCR-RFLP method was used to determine MMP-9 polymorphism in 18 prostate cancer cases, 4 benign prostate hyperplasia cases, 14 invasive bladder cancer cases, 5 non-invasive bladder cancer cases, 4 renal cancer cases and 1 adrenal gland cancer case.
Results: Prevalence of C/C, C/T, T/T genotypes was similar among bladder and renal cancer patients. In prostate cancer patients a significant association (P = 0.0052) between clinical stage and MMP-9 polymorphism was found.
Conclusion: Our data demonstrate that MMP-9 (-1562 C/T) polymorphism may modify susceptibility to prostate cancer. We hypothesized that this polymorphism might act as a genetic modifier in the development and progression of prostate cancer.
Additional studies with larger population are warranted. Background: Despite compelling data demonstrating a direct link between altered expression of S100 proteins located on human chromosome 1q21 and epithelial malignancies, the knowledge of their function and mode of action in epithelial cells and in tumor promotion or progression is largely unknown.
Methods: Gene expression profiling of the in vivo model of chemically induced skin carcinogenesis revealed differential regulation of genes coding for S100 proteins. Subsequent studies using in vitro models and tissue microarrays are currently extended by to suitable in vivo models.
Results: Here, we have identified a novel signaling pathway in epithelial cells initiated by extracellular S100A8/A9 resulting in the activation of AP-1-dependent gene expression. Importantly, co-expression of S100A3 inhibits S100A8/A9 mediated AP-1 activation, which is in line with repression of this gene during skin carcinogenesis suggesting a negative role for S100A3 in epithelial malignancy. We found elevated levels of MMP2 and MMP9, two well-known AP-1 regulated genes, and identified S100A6 as an additional target gene of S100A8/A9 signaling. Moreover, significant co-expression of S100A8 and S100A9 together with phosphorylation of c-Jun and elevated S100A6 protein levels were evident in eSCC. The in vivo relevance of S100A8/A9 interaction with RAGE is discussed.
Conclusion:
Our data suggest that targeting the net activity of S100 induced signaling represents an auspicious strategy for cancer prevention and/or therapy. Methods: In synchronized U2OS cells, we inhibited Chk1 kinase by the specific inhibitor CEP-3891 and manipulated this system using different constructs and siRNAs.
Results: Chk1 inhibition induced premature mitotic entry displaying regular spindles but deficient chromatin condensationwhich we have termed the 'paraspindle' phenotype -, apparently resulting in mitotic nuclear fragmentation. The paraspindle phenotype was reverted by inhibition of the Cdc25B phosphatase using siRNA, which restored normal mitoses with regular chromosome condensation. antibodies was done using the standard protocol. TRANSFAC database was used to scan the sequence for putative transcription factor binding sites.
Results:
All the three cell lines tested showed high constitute expression of CSS1 mRNA and showed more or less similar pattern of promoter activity for different deletion constructs of CSS1, with construct À121 to +274 showing the highest activity.
Region À55 to À25 seems to be important for the core promoter activity, this region contains a putative NRF1 biding site. NRF1
was found to bind to this region in EMSA. Interestingly, deletion construct À55 to À2 which has lost the first noncoding exonic region showed complete lack of promoter activity, suggesting that the first noncoding exon containing putative AP-1-and Ets-1-binding sites is required for basal promoter activity. Binding of AP-1-transcription factors to this exonic region has already been confirmed in gelshift analysis. E J C S U P P L E M E N T S 4 ( 2 0 0 6 ) 2 7 -5 3
Conclusion

